What is the Market's View on Immunoprecise Antibodies Ltd (IPA) Stock's Price and Volume Trends Friday?

The market has been neutral on Immunoprecise Antibodies Ltd (IPA) stock recently. IPA gets a Neutral score from InvestorsObserver Stock Sentiment Indicator.

Immunoprecise Antibodies Ltd has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on IPA!

See Full IPA Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With IPA Stock Today?

Immunoprecise Antibodies Ltd (IPA) stock is trading at $1.49 as of 2:08 PM on Friday, Mar 15, a decline of -$0.11, or -6.6% from the previous closing price of $1.59. The stock has traded between $1.42 and $1.57 so far today. Volume today is light. So far 260,397 shares have traded compared to average volume of 1,102,542 shares. To screen for more stocks like Immunoprecise Antibodies Ltd click here.

More About Immunoprecise Antibodies Ltd

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United States of America. Click Here to get the full Stock Report for Immunoprecise Antibodies Ltd stock.